Retraction Note: Interactions between Th1 cells and Tregs affect regulation of hepatic fibrosis in biliary atresia through the IFN-γ/STAT1 pathway (Cell Death & Differentiation, (2017), 24, 6, (997-1006), 10.1038/cdd.2017.31);Interactions between Th1 cells and Tregs affect regulation of hepatic fibrosis in biliary atresia through the IFN- 3/STAT1 pathway

Cell Death and Differentiation

Volumn 24, Issue 6, 2017, Pages 997-1006

  Wen, Jie ^a,b,c   Zhou, Ying ^a   Wang, Jun ^a   Chen, Jie ^a   Yan, Wenbo ^a   Wu, Jin ^b,c   Yan, Junkai ^b,c   Zhou, Kejun ^b,c   Xiao, Yongtao ^b,c   Wang, Yang ^b,c   Xia, Qiang ^a   Cai, Wei ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition   (China)

^c Shanghai Institute of Pediatric Research   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GELATINASE A; STAT1 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; STAT1 PROTEIN, HUMAN;

ARTICLE; BILE DUCT ATRESIA; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; EXTRACELLULAR MATRIX; FIBROGENESIS; FLOW CYTOMETRY; HEPATIC STELLATE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFANT; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION; COMPLICATION; IMMUNOLOGY; LIVER CIRRHOSIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

BILIARY ATRESIA; CELL PROLIFERATION; HEPATIC STELLATE CELLS; HUMANS; INFANT; INTERFERON-GAMMA; LIVER CIRRHOSIS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

EID: 85015624004     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/s41418-019-0428-0     Document Type: Erratum

References (30)

1. Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet 2009; 374: 1704-1713.
2. Petersen C, Davenport M. Aetiology of biliary atresia: what is actually known? Orphanet J Rare Dis 2013; 8: 128.
3. Sokol RJ, Mack C, Narkewicz MR, Karrer FM. Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr 2003; 37: 4-21.
4. Selmi C, Vergani D, Mieli-Vergani G. Viruses and autoantibodies in biliary atresia. Gastroenterology 2010; 139: 1461-1464.
5. Tucker RM, Feldman AG, Fenner EK, Mack CL. Regulatory T cells inhibit Th1 cell-mediated bile duct injury in murine biliary atresia. J Hepatol 2013; 59: 790-796.
6. Mack CL, Tucker RM, Sokol RJ, Kotzin BL. Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia. Clin Immunol 2005; 115: 200-209.
7. Mack CL, Tucker RM, Lu BR, Sokol RJ, Fontenot AP, Ueno Y et al. Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia. Hepatology 2006; 44: 1231-1239.
8. Klemann C, Schroder A, Dreier A, Mohn N, Dippel S, Winterberg T et al. Interleukin 17, produced by gammadelta T cells, contributes to hepatic inflammation in a mouse model of biliary atresia and is increased in livers of patients. Gastroenterology 2016; 150: 229-241 e225.
9. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30: 899-911.
10. Haafiz AB. Liver fibrosis in biliary atresia. Expert Rev Gastroenterol Hepatol 2010; 4: 335-343.
11. Kyoden Y, Tamura S, Sugawara Y, Yamashiki N, Matsui Y, Togashi J et al. Outcome of living donor liver transplantation for post-Kasai biliary atresia in adults. Liver Transpl 2008; 14: 186-192.
12. Karakayali H, Sevmis S, Ozcelik U, Ozcay F, Moray G, Torgay A et al. Liver transplantation for biliary atresia. Transplant Proc 2008; 40: 231-233.
13. Harpavat S, Garcia-Prats JA, Shneider BL. Newborn bilirubin screening for biliary atresia. N Engl J Med 2016; 375: 605-606.
14. Guidotti LG, Chisari FV. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 2006; 1: 23-61.
15. Spengler U, Nattermann J. Immunopathogenesis in hepatitis C virus cirrhosis. Clin Sci (Lond) 2007; 112: 141-155.
16. Langhans B, Kramer B, Louis M, Nischalke HD, Huneburg R, Staratschek-Jox A et al. Intrahepatic IL-8 producing Foxp3(+)CD4(+) regulatory T cells and fibrogenesis in chronic hepatitis C. J Hepatol 2013; 59: 229-235.
17. Langhans B, Alwan AW, Kramer B, Glassner A, Lutz P, Strassburg CP et al. Regulatory CD4 + T cells modulate the interaction between NK cells and hepatic stellate cells by acting on either cell type. J Hepatol 2015; 62: 398-404.
18. Li J, Bessho K, Shivakumar P, Mourya R, Mohanty SK, Dos Santos JL et al. Th2 signals induce epithelial injury in mice and are compatible with the biliary atresia phenotype. J Clin Invest 2011; 121: 4244-4256.
19. Shivakumar P, Campbell KM, Sabla GE, Miethke A, Tiao G, McNeal MM et al. Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia. J Clin Invest 2004; 114: 322-329.
20. Brindley SM, Lanham AM, Karrer FM, Tucker RM, Fontenot AP, Mack CL. Cytomegalovirusspecific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells. Hepatology 2012; 55: 1130-1138.
21. Mack CL, Tucker RM, Sokol RJ, Karrer FM, Kotzin BL, Whitington PF et al. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatr Res 2004; 56: 79-87.
22. Shivakumar P, Sabla G, Mohanty S, McNeal M, Ward R, Stringer K et al. Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia. Gastroenterology 2007; 133: 268-277.
23. Visse R. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-839.
24. Xiao Y, Wang J, Chen Y, Zhou K, Wen J, Wang Y et al. Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K/Akt signaling. Cell Signal 2014; 26: 925-932.
25. Fielding CA, Jones GW, McLoughlin RM, McLeod L, Hammond VJ, Uceda J et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity 2014; 40: 40-50.
26. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 2004; 4: 583-594.
27. Gurujeyalakshmi G, Giri SN. Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. Exp Lung Res 1995; 21: 791-808.
28. Mellor AL, Chandler P, Baban B, Hansen AM, Marshall B, Pihkala J et al. Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. Int Immunol 2004; 16: 1391-1401.
29. Walker LS, Sansom DM. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat Rev Immunol 2011; 11: 852-863.
30. Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003; 4: 1206-1212.